{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-24-000009","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.938068+00:00","generated_at":"2026-06-05T21:50:47.546069+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Supernus SVP Regulatory Affairs retires; successor Roman Bradel to join in March 2024","bullets":["Tami T. Martin notified retirement effective May 3, 2024.","Roman Bradel expected to join March 2024 as VP Regulatory Affairs.","Bradel will report to Frank Mottola, SVP Quality, GMP Operations and IT."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-24-000009","json":"https://secwatch.observer/filing/0001356576-24-000009.json","markdown":"https://secwatch.observer/filing/0001356576-24-000009.md","text":"https://secwatch.observer/filing/0001356576-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/supn-20240214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:50:47.546069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3d021760f7","claim":"Roman Bradel was appointed as Vice President, Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC..","evidence_excerpt":"The Company expects Roman Bradel, Ph.D. to join the Company in March 2024 as its Vice President, Regulatory Affairs reporting to Frank Mottola, the Company’s Senior Vice President, Quality, GMP Operations and IT.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President, Regulatory Affairs"}],"fact_type":"executive_change"},{"claim_id":"9ba83ef4a9","claim":"Tami T. Martin retired as Senior Vice President, Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC..","evidence_excerpt":"Tami T. Martin, R.N., Esq., the Company’s Senior Vice President, Regulatory Affairs, notified Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) of her retirement from the Company effective May 3, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Senior Vice President, Regulatory Affairs"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}